Fighting infection: the role of lipopolysaccharide binding proteins CD14 and LBP

Area of Science:

• Immunology
• Microbiology

Background:

• The innate immune system provides initial defense against pathogens until adaptive immunity develops.
• Pattern recognition receptors, such as CD14 and lipopolysaccharide (LPS) binding protein (LBP), recognize conserved microbial molecules like LPS.
• LPS binding protein (LBP) is critical for initiating inflammatory responses by mediating LPS binding to membrane-bound CD14 (mCD14) on macrophages.

Purpose of the Study:

• To investigate the role of lipopolysaccharide (LPS) binding protein (LBP) in controlling Gram-negative bacterial infections.
• To elucidate the mechanisms by which LBP contributes to macrophage activation and pathogen clearance.

Main Methods:

• Utilized LBP-deficient mice to assess infection control.
• Investigated the role of LBP and mCD14 in the recognition and phagocytosis of bacteria in vitro.
• Assessed the generation of reactive oxygen species in macrophages stimulated by live bacteria in the presence or absence of LBP.

Main Results:

• LBP mediates the binding of lipopolysaccharide (LPS) to membrane-bound CD14 (mCD14), initiating a proinflammatory macrophage response.
• In vitro studies demonstrated that mCD14 and LBP are involved in the recognition and phagocytosis of heat-killed bacteria.
• Live Salmonella typhimurium and Escherichia coli require LBP for inducing reactive oxygen species generation in macrophages.
• LBP-deficient mice showed impaired control of low-dose Salmonella typhimurium infection.

Conclusions:

• LPS binding protein (LBP) plays an essential role in the innate immune response against Gram-negative bacterial infections.
• LBP is pivotal in both the physiological and pathophysiological processes related to Gram-negative infections, highlighting its importance in host defense.